Home/Filings/4/0000899243-18-024043
4//SEC Filing

TURKEL CATHERINE C. 4

Accession 0000899243-18-024043

CIK 0001404281other

Filed

Sep 6, 8:00 PM ET

Accepted

Sep 7, 8:00 PM ET

Size

5.3 KB

Accession

0000899243-18-024043

Insider Transaction Report

Form 4
Period: 2018-09-05
TURKEL CATHERINE C.
Chief Development Officer
Transactions
  • Purchase

    Common Stock

    2018-09-05$3.97/sh+805$3,193805 total(indirect: By Spouse)
Holdings
  • Common Stock

    44,519

Issuer

Novus Therapeutics, Inc.

CIK 0001404281

Entity typeother

Related Parties

1
  • filerCIK 0001705278

Filing Metadata

Form type
4
Filed
Sep 6, 8:00 PM ET
Accepted
Sep 7, 8:00 PM ET
Size
5.3 KB